Condition category
Surgery
Date applied
30/06/2005
Date assigned
08/07/2005
Last edited
14/09/2009
Prospective/Retrospective
Retrospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Not provided at time of registration

Trial website

Contact information

Type

Scientific

Primary contact

Dr Fotis Kanakoudis

ORCID ID

Contact details

Korytsas 14
Thessaloniki
55133
Greece
+30 2310437531
fkanak@otenet.gr

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

N/A

Study information

Scientific title

Acronym

PRAECS

Study hypothesis

Null hypothesis:Patients receiving intravenous ethanol would not require smaller doses of propofol and remifentanil for induction and maintenance of anaesthesia.

Ethics approval

Not provided at time of registration

Study design

Randomised controlled trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

Not specified

Trial type

Not Specified

Patient information sheet

Condition

Interaction of acute ethanol intravenous intake with propofol (general anesthetic) and remifentanil (opioid)

Intervention

Comparison of two groups (with different ethanol doses) versus control (no ethanol), regarding propofol and remifentanil requirements

Intervention type

Drug

Phase

Not Specified

Drug names

Propofol, remifentanil and acute ethanol

Primary outcome measures

Reduction of propofol and remifentanil requirements

Secondary outcome measures

Degree of reduction, side-effects

Overall trial start date

02/02/2004

Overall trial end date

07/06/2004

Reason abandoned

Eligibility

Participant inclusion criteria

Female surgical patients on general anesthesia

Participant type

Patient

Age group

Adult

Gender

Female

Target number of participants

60

Participant exclusion criteria

Alcoholic patients, patients in abstinence

Recruitment start date

02/02/2004

Recruitment end date

07/06/2004

Locations

Countries of recruitment

Greece

Trial participating centre

Korytsas 14
Thessaloniki
55133
Greece

Sponsor information

Organisation

Theagenio Anticancer Hospital of Thessaloniki (Greece)

Sponsor details

Al. Symeonidis 2
Thessaloniki
54007
Greece
+30 2310898213
amitragas@yahoo.com

Sponsor type

Hospital/treatment centre

Website

http://www.theagenio.gr

Funders

Funder type

Hospital/treatment centre

Funder name

Theagenio Anticancer Hospital of Thessaloniki (Greece)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

Publication citations

Additional files

Editorial Notes